Loading university
Peter James Turnbaugh — Dr. Peter Turnbaugh's lab focuses on understanding how the gut microbiome influences the metabolism of cancer drugs, particularly fluoropyrimidines used in colorectal cancer treatment. By examining the interactions between gut bacteria and these drugs, the research aims to reveal why there are differences in drug effectiveness and side effects among patients. This work could lead to better treatment strategies that take into account individual differences in gut microbiota.
Thomas E Ferrin — Professor Thomas E Ferrin's lab focuses on creating advanced software tools for visualizing and analyzing complex molecular structures. Their primary program, ChimeraX, allows researchers to interact with detailed biological data, helping to uncover insights about diseases and drug targets. The lab aims to make these powerful tools accessible to scientists worldwide, enhancing our understanding of molecular biology and contributing to improvements in biomedical research.
Lily Jan — Dr. Lily Jan's lab at UCSF focuses on understanding a family of proteins known as TMEM16, which play crucial roles in how neurons communicate and regulate various physiological functions. Through techniques such as cryo-electron microscopy and site-directed mutagenesis, the lab investigates how these proteins function as ion channels and lipid scramblases, contributing to exciting areas like neurodegeneration and pain sensitivity. This research is essential for uncovering the mechanisms behind human diseases linked to these proteins.
Yuh Nung Jan — Dr. Yuh Nung Jan's lab at UCSF focuses on understanding how dendrites, the branches of neurons that receive signals, develop and regenerate. The lab uses fruit flies to uncover the genetic and molecular mechanisms that control these processes. This research is important since defects in dendrite development can be linked to neurological disorders like autism and Down syndrome. By studying how neurons communicate and respond to injury, the lab aims to contribute to potential treatments for these conditions.
William W Seeley — Dr. William W. Seeley's lab at UCSF focuses on understanding the causes of frontotemporal dementia and motor neuron disease, two worsening neurodegenerative disorders. They investigate the role of certain proteins, like TDP-43, that misbehave in these conditions. By studying brain samples, they aim to find new insights that could lead to better treatments for these challenging diseases.
David Julius — Dr. David Julius's lab at UCSF focuses on understanding how we perceive pain through the study of specialized nerve fibers called nociceptors. His team investigates the molecular and physiological mechanisms that allow these nociceptors to detect harmful stimuli and transmit pain signals, especially in the context of chronic pain conditions like arthritis and gastrointestinal disorders. By combining advanced techniques from structural biology to integrative physiology, the lab aims to contribute to the development of new pain therapies and improve patients' quality of life.
Heather J Fullerton — Dr. Heather J. Fullerton's lab focuses on understanding the disease process and treatment options for a condition called focal cerebral arteriopathy (FCA), which is a leading cause of strokes in children. The lab is conducting a clinical trial (FOCAS) to compare two treatment strategies using corticosteroids to see which one leads to better health outcomes for affected children. They aim to ensure that children receiving treatment have the best chance of recovery and improvement in their neurological health.
Joel H Kramer — Dr. Joel H. Kramer and his lab at UCSF focus on understanding small vessel cerebrovascular disease, particularly how it contributes to cognitive decline in older adults. They aim to identify reliable markers that can help detect and monitor this disease early on, improving how we diagnose and treat affected patients. By following a diverse group of older individuals showing signs of cerebrovascular issues, they are working to validate new neuroimaging and fluid-based biomarkers that could greatly enhance clinical trials and patient care.
Brian K Shoichet — Professor Brian K. Shoichet's lab focuses on creating new methods for discovering potential drugs by using computational and experimental approaches. They especially aim to understand how different molecules interact with biological targets, like proteins, to influence health and disease. The lab works on large libraries of compounds to test how changes in these libraries affect drug discovery outcomes, aiming to find new insights into drug interactions and delivery methods.